High-resolution magnetic resonance colonography and dynamic contrast-enhanced magnetic resonance imaging in a murine model of colitis

Magnetic Resonance in Medicine

Volumn 63, Issue 4, 2010, Pages 922-929

  Mustafi, Devkumar ^a   Fan, Xiaobing ^a   Dougherty, Urszula ^a   Bissonnette, Marc ^a   Karczmar, Gregory S ^a   Oto, Aytekin ^a   Hart, John ^a   Markiewicz, Erica ^a   Zamora, Marta ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Dextran sulfate sodium induced colitis; Dynamic contrast enhanced MRI; MRI and histology correlation; Murine model of colitis; Quantitative pharmacokinetic analysis of DCEMRI

Indexed keywords

DEXTRAN; DISEASES; IMAGE ENHANCEMENT; MAMMALS; POTABLE WATER; SODIUM; SULFUR COMPOUNDS;

DCE-MRI; DEXTRAN SULFATE SODIUM; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC CONTRAST ENHANCED MRI; INFLAMMATORY BOWEL DISEASE; MURINE MODEL; PRECLINICAL IMAGING; ULCERATIVE COLITIS;

MAGNETIC RESONANCE IMAGING;

GADODIAMIDE; GADOLINIUM PENTETATE;

ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; HISTOLOGY; IN VIVO STUDY; MAGNETIC RESONANCE COLONOGRAPHY; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; QUANTITATIVE ANALYSIS;

EID: 77950599057     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22229     Document Type: Article

References (32)

1. Strober W, Fuss I, Mannon P. The fundamental basis of inflammatory bowel disease. J Clin Invest 2007; 117: 514-521.
2. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3:521-533.
3. Gore RM, Balthazar EJ, Ghahremani GG, Miller FH. CT features of ulcerative colitis and Crohn's disease. AJR Am J Roentgenol 1996; 167: 3-15.
4. Thoeni RF, Cello JP. CT imaging of colitis. Radiology 2006; 240: 623-638.
5. Pradel JA, David XR, Taourel P, Djafari M, Veyrac M, Bruel JM. Sonographic assessment of the normal and abnormal bowel wall in nondiverticular ileitis and colitis. Abdom Imaging 1997; 22:167-172.
6. Limberg B, Osswald B. Diagnosis and differential diagnosis of ulcerative colitis and Crohn's disease by hydrocolonic sonography. Am J Gastroenterol 1994; 89:1051-1057.
7. Sadetzki S. Excess lifetime cancer mortality risk attributed to radiation exposure from pediatric computed tomography scan. Isr Med Assoc J 2007; 9: 607-609.
8. Martin DR, Lauenstein T, Sitaraman SV. Utility of magnetic resonance imaging in small bowel Crohn's disease. Gastroenterology 2007;133:385-390.
9. Florie J, Wasser MNJM, Arts-Cieslik K, Akkerman EM, Siersema PD, Stroker J. Dynamic contrast-enhanced MRI of the bowel wall for assessment of disease in Crohn's disease. AJR Am J Roentgenol 2006; 186:1384-1392.
10. Pupillo VA, Di Cesare E, Frieri G, Limbucci N, Tanga M, Masciocchi C. Assessment of inflammatory activity in Crohn's disease by means of dynamic contrast-enhanced MRI. Radiol Med 2007;112:798-809.
11. del Vescovo R, Sansoni I, Caviglia R, Ribolsi M, Perrone G, Leoncini E, Grasso RF, Cicala M, Zobel BB. Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease. Abdom Imaging 2008; 33: 417-424.
12. Oto A, Fan X, Mustafi D, Jansen JA, Karczmar GS, Rubin DT, Kayhan A. Quantitative analysis of dynamic contrast enhanced MRI for assessment of bowel inflammation in Crohn's disease: pilot study. Acad Radiol DOI: 10.1016/j.acra.2009.04.010.
13. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
14. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 1993; 69: 238-249.
15. Okayasu I, Ohkusa T, Kajiura K, Kanno J, Sakamoto S. Promotion of colorectal neoplasia in experimental murine ulcerative colitis. Gut 1996; 39: 87-92.
16. Larsson AE, Melger S, Rehnstrom E, Michaelsson E, Svensson L, Hockings P, Olsson LE. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity. Inflamm Bowel Dis 2006; 12:478-485.
17. Melger S, Gillberg P-G, Hockings PD, Olsson LE. High-throughput magnetic resonance imaging in murine colonic inflammation. Biochem Biophys Res Commun 2007; 355:1102-1107.
18. Young MR, Ileva LV, Bernardo M, Riffle LA, Jones YL, Kim YS, Colburn NH, Choyke PL. Monitoring of tumor promotion and progression in a mouse model of inflammation-induced colon cancer with magnetic resonance colonography. Neoplasia 2009; 11:237-246.
19. z.ast; measurements for AIF assessment combined with DCE MRI in a mouse tumor model. MAGMA 2007; 20:193-203.
20. Hensley HH, Chang W-C, Clapper ML. Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging. Magn Reson Med 2004; 52: 524-529.
21. Tao Y, Hart J, Lichtenstein L, Joseph LJ, Ciancio MJ, Hu S, Chang EB, Bissonnette M. Inducible heat shock protein 70 prevents multifocal flat dysplasia lesions and invasive tumors in an inflammatory model of colon cancer. Carcinogenesis 2009; 30:175-182.
22. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrastenhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-232.
23. Brix G, Seminmler W, Port R, Schad LR, Layer G, Lorenz WJ. Pharmacokinetic parameters in CNS Gd (DTPA) enhanced MR imaging. J Comput Assist Tomogr 1991; 15: 621-628.
24. Medved M, Karczmar G, Yang C, Dignam J, Gajewski TF, Kindler H, Vokes E, MacEneany P, Mitchell MT, Stadler WM. Semiquantitative analysis of dynamic contrast enhanced MRI in cancer patients: Variability and changes in tumor tissue over time. J Magn Reson Imaging 2004; 20:122-128.
25. Fan X, Medved M, River JN, Zamora M, Corot C, Robert P, Bourrinet P, Lipton M, Culp RM, Karczmar GS. New model for analysis of dynamic contrast-enhanced MRI data distinguishes metastatic from nonmetastatic transplanted rodent prostate tumors. Magn Reson Med 2004; 51:487-494.
26. Fan X, Medved M, Karczmar GS, Yang C, Foxley S, Arkani S, Recant W, Zamora MA, Abe H, Newstead GM. Diagnosis of suspicious breast lesions using an empirical mathematical model for dynamic contrastenhanced MRI. Magn Reson Imaging 2007; 25:593-603.
27. Maccioni F, Colaiacomo MC, Parlanti S. Ulcerative colitis: value of MR imaging. Abdom Imaging 2005; 30:584-592.
28. Gouya H, Vignaux O, Le Roux P, Chanson P, Bertherat J, Bertagna X, Legmann P. Rapidly reversible myocardial edema in patents with acromegaly: assessment with ultrafast T2 mapping in a single-breathhold MRI sequence. AJR Am J Roentgenol 2008; 190: 1576-1582.
29. Oh J, Cha S, Aiken AH, Han ET, Crane JC, Stainsby JA, Wright GA, Dillon WP, Nelson SJ. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging 2005; 21:701-708.
30. Brahme F, Lindstrom C. A comparative radiographic and pathological study of intestinal vaso-architecture in Crohn's disease and in ulcerative colitis. Gut 1970; 11:928-940.
31. Danse S, Sans M, Motte CDL, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006; 130:2060-2073. (Pubitemid 43816964)
32. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, Subbaramaiah K, Cooper HS, Itzkowitz SH, Abreu T. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133: 1869-1881.